No quarterly revenue total was found in Bluejay Diagnostics, Inc.'s SEC filings.
Bluejay Diagnostics, Inc. (BJDX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$1.6 million. As of Jun 30, 2026 it held $9.6 million in cash and investments and $80,670 in total debt.
Revenue
—
Net income
$-2.32M
-18.8% vs year-ago quarter
Operating cash flow
$-1.50M
+27.0% vs year-ago quarter
Free cash flow
$-1.64M
-2.1% vs prior quarter
EPS
$-1.12
+80.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
4.47M
+199.0% vs year-ago quarter
Net cash
$9.52M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BJDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Acton, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1704287
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$2.3M | -$1.9M | -$1.5M | -$1.6M | -$2.0M |
| Net income | -$2.3M | -$1.9M | -$1.4M | -$1.6M | -$2.0M |
| Diluted EPS | -$1.12 | -$1.95 | $0.85 | -$1.01 | -$5.64 |
| Operating cash flow | -$1.5M | -$1.6M | -$1.5M | -$1.4M | -$2.1M |
| Free cash flow | -$1.6M | -$1.6M | -$1.6M | — | — |
| Total assets | $11.5M | $5.6M | $7.1M | $4.9M | $6.4M |
| Total liabilities | $2.1M | $1.4M | $1.1M | $1.2M | $1.1M |
| Stockholders' equity | $9.4M | $4.2M | $6.0M | $3.7M | $5.3M |
| Cash and investments | $9.6M | $3.7M | $5.2M | $3.1M | $4.4M |
| Total debt | $80,670 | $105,328 | $129,558 | $153,372 | $176,773 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Nov 4, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 8, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
All 249 Bluejay Diagnostics, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.